The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
- PMID: 37339849
- PMCID: PMC10423477
- DOI: 10.1136/gutjnl-2023-329948
The first international Rome consensus conference on gut microbiota and faecal microbiota transplantation in inflammatory bowel disease
Abstract
Background: Several randomised clinical trials (RCTs) performing faecal microbiota transplantation (FMT) for the management of inflammatory bowel disease (IBD), particularly for ulcerative colitis, have recently been published, but with major variations in study design. These include differences in administered dose, route and frequency of delivery, type of placebo and evaluated endpoints. Although the overall outcomes appear to be promising, they are highly dependent on both donor and recipient factors.
Objective: To develop concensus-based statements and recommendations for the evaluation, management and potential treatment of IBD using FMT in order to move towards standardised practices.
Design: An international panel of experts convened several times to generate evidence-based guidelines by performing a deep evaluation of currently available and/or published data. Twenty-five experts in IBD, immunology and microbiology collaborated in different working groups to provide statements on the following key issues related to FMT in IBD: (A) pathogenesis and rationale, (B) donor selection and biobanking, (C) FMT practices and (D) consideration of future studies and perspectives. Statements were evaluated and voted on by all members using an electronic Delphi process, culminating in a plenary consensus conference and generation of proposed guidelines.
Results and conclusions: Our group has provided specific statements and recommendations, based on best available evidence, with the end goal of providing guidance and general criteria required to promote FMT as a recognised strategy for the treatment of IBD.
Keywords: INFLAMMATORY BOWEL DISEASE; INTESTINAL MICROBIOLOGY; ULCERATIVE COLITIS.
© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
Role of fecal microbiota transplantation in inflammatory bowel disease.J Dig Dis. 2018 Jun;19(6):322-334. doi: 10.1111/1751-2980.12603. Epub 2018 May 29. J Dig Dis. 2018. PMID: 29696802 Review.
-
Fecal transplantation for treatment of inflammatory bowel disease.Cochrane Database Syst Rev. 2018 Nov 13;11(11):CD012774. doi: 10.1002/14651858.CD012774.pub2. Cochrane Database Syst Rev. 2018. Update in: Cochrane Database Syst Rev. 2023 Apr 25;4:CD012774. doi: 10.1002/14651858.CD012774.pub3. PMID: 30480772 Free PMC article. Updated.
-
Australian consensus statements for the regulation, production and use of faecal microbiota transplantation in clinical practice.Gut. 2020 May;69(5):801-810. doi: 10.1136/gutjnl-2019-320260. Epub 2020 Feb 11. Gut. 2020. PMID: 32047093 Review.
-
European consensus conference on faecal microbiota transplantation in clinical practice.Gut. 2017 Apr;66(4):569-580. doi: 10.1136/gutjnl-2016-313017. Epub 2017 Jan 13. Gut. 2017. PMID: 28087657 Free PMC article.
-
Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases?Dig Dis. 2016;34 Suppl 1:74-81. doi: 10.1159/000447379. Epub 2016 Aug 22. Dig Dis. 2016. PMID: 27548724
Cited by
-
Impact of Clostridioides difficile Infection on Clinical Outcomes in Hospitalized IBD Patients and the Role of Fecal Microbiota Transplantation: A Retrospective Cohort Study.Kaohsiung J Med Sci. 2025 May;41(5):e70002. doi: 10.1002/kjm2.70002. Epub 2025 Mar 17. Kaohsiung J Med Sci. 2025. PMID: 40091757 Free PMC article.
-
Current landscape of fecal microbiota transplantation in treating depression.Front Immunol. 2024 Jun 25;15:1416961. doi: 10.3389/fimmu.2024.1416961. eCollection 2024. Front Immunol. 2024. PMID: 38983862 Free PMC article. Review.
-
Advances in research on the role of high carbohydrate diet in the process of inflammatory bowel disease (IBD).Front Immunol. 2024 Nov 11;15:1478374. doi: 10.3389/fimmu.2024.1478374. eCollection 2024. Front Immunol. 2024. PMID: 39588368 Free PMC article. Review.
-
Virome drift in ulcerative colitis patients: faecal microbiota transplantation results in minimal phage engraftment dominated by microviruses.Gut Microbes. 2025 Dec;17(1):2499575. doi: 10.1080/19490976.2025.2499575. Epub 2025 May 15. Gut Microbes. 2025. PMID: 40371968 Free PMC article.
-
The protective role of commensal gut microbes and their metabolites against bacterial pathogens.Gut Microbes. 2024 Jan-Dec;16(1):2356275. doi: 10.1080/19490976.2024.2356275. Epub 2024 May 26. Gut Microbes. 2024. PMID: 38797999 Free PMC article.
References
-
- Cammarota G, Masucci L, Ianiro G, et al. Randomised clinical trial: faecal microbiota transplantation by colonoscopy vs. vancomycin for the treatment of recurrent Clostridium difficile infection. Aliment Pharmacol Ther 2015;41:835–43. Available http://doi.wiley.com/10.1111/apt.2015.41.issue-9 10.1111/apt.13144 - DOI - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical